Cargando…
A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
BACKGROUND: The potency of inactivated influenza vaccines is determined using a single‐radial immunodiffusion (SRID) assay and requires standardized reagents consisting of a Reference Antigen and an influenza strain‐specific antiserum. Timely availability of reagents is a critical step in influenza...
Autores principales: | Schmeisser, Falko, Jing, Xianghong, Joshi, Manju, Vasudevan, Anupama, Soto, Jackeline, Li, Xing, Choudhary, Anil, Baichoo, Noel, Resnick, Josephine, Ye, Zhiping, McCormick, William, Weir, Jerry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746557/ https://www.ncbi.nlm.nih.gov/pubmed/26616263 http://dx.doi.org/10.1111/irv.12365 |
Ejemplares similares
Cargando…
ANTISERA, TOXOIDS, VACCINES AND TUBERCULINS IN PROPHYLAXIS AND TREATMENT
Publicado: (1961)
Publicado: (1961)
Ejemplares similares
-
Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017) -
A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines
por: Schmeisser, Falko, et al.
Publicado: (2014) -
Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017) -
Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza
por: Vodeiko, Galina M., et al.
Publicado: (2011) -
Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)